Protective effect of nerve growth factor combined with mecobalamine on optic nerve and influence on MMP-2 and TIMP-2
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [16]
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    AIM: To investigate the protective effect of nerve growth factor(NGF)combined with mecobalamine on optic nerve and the influence on matrix metalloproteinase-2(MMP-2), tissue inhibitor of matrix metalloprotease-2(TIMP-2).

    METHODS: Totally 54 patients(73 eyes)with acute angle closure glaucoma undergoing trabeculectomy was included in the study, and the patients were divided into the control group(30 cases, 35 eyes)and combination group(24 cases, 38 eyes)according to the digital table method. The patients in the control group were treated with mecobalamine, and the patients in combination group were treated with NGF combined with mecobalamine. Visual acuity, intraocular pressure, mean light sensitivity(MS), visual field mean defect(MD), retinal nerve fibre layer(RNFL)thickness, the nipple cup/disc ratio, P100 wave incubation period and amplitude of P100 wave, neuron-specific enolase(NSE), nitric oxide(NO), nitric oxide synthase(NOS), matrix metalloproteinase-2(MMP-2), metalloproteinases tissue inhibiting factor-2(TIMP-2)before and after treatment were observed in the two groups. The adverse reactions during medication were supervised.

    RESULTS: Compared with those before treatment, visual acuity, MS, and P100 wave amplitudes increased, MD and P100 wave latency decreased(P<0.05)after treatment, the change ranges in combination group were greater than those in control group(P<0.05). There was no significant change in intraocular pressure, RNFL, the nipple cup/disc ratio before and after treatment in the two groups(P>0.05). Compared with those before treatment, serum NO, NOS, MMP-2 levels in the two groups increased, and the levels of NES, TIMP-2, TIMP-2/MMP-2 decreased(P<0.05), but the change degrees in combination group were greater than those in control group(P<0.05).

    CONCLUSION: NGF combined with mecobalamine can improve postoperative visual function of glaucoma, which has certain regulatory effects on MMP-2 and TIMP-2.

    Reference
    1胡瑛,庄曾渊,张丽霞,等.青光眼视神经保护的研究进展.中国医药导报 2011; 8(29):8-9
    2朱敏,李国培,赵刚平,等.小梁切除术联合甲钴胺药物治疗晚期青光眼. 广东医学 2010; 31(2):219-220
    3单明华,王云松. 注射用鼠神经生长因子治疗视神经挫伤的疗效观察.广州医学院学报 2013; 41(1):29-30
    4苗森,乔春艳.先天性青光眼的手术治疗进展.中华眼科杂志 2014; 50(8):626-629
    5 Spinnler K,Frohlich T,Arnold GJ,et al.Human tryptase cleaves pro-nerve growth factor(pro-NGF): hints of local,mast cell-dependent regulation of NGF/pro-NGF action. J Biol Chem 2011; 286(36):31707-31713
    6鲁铭,高媛,罗艳,等. 川芎嗪联合甲钴胺对晚期青光眼术后视功能的影响.武汉大学学报(医学版)2009; 30(3):362-364
    7 Tirassa P.The nerve growth factor administrated as eye drops activates mature and precursor cells in subventricular zone of adult rats. Arch Ital Biol 2011; 149(2):205-213
    8罗丽华,王艳玲.神经生长因子联合传统用药对前部缺血性视神经病变的疗效.国际眼科杂志 2013; 13(9):1842-1844
    9孙路建.鼠神经生长因子联合长春西汀治疗急性闭角型青光眼视神经损伤.现代中西医结合杂志 2010; 19(30):3283-3284
    10蒋艳华. 神经生长因子对青光眼的保护作用与机制探讨.医学综述 2015; 21(21):4020-4022
    11孙小单,李羽佳.神经生长因子促神经再生作用的研究进展.辽宁医学院学报 2010; 31(4):377-380
    12陈莲,石晶明.青光眼患者视网膜神经节细胞凋亡机制的研究进展.眼科新进展 2013; 33(4):384-388
    13 Ashworth Briggs EL, Toh T, Eri R, et al. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients. Mol Vis 2015; 13(21):1162-1172
    14俞建雄,袁静,周炼红.角膜基质细胞基质金属蛋白酶 1,2 活性与组织因子途径抑制物2的效应.中国组织工程研究 2014; 18(2): 251-258
    15杨育彬. 脑蛋白水解物注射剂对原发性青光眼患者血清金属蛋白酶2组织抑制因子和视神经功能的影响.中国医院用药评价与分析 2016; 16(2):174-176
    16刘梦迎,王玲,王大博,等. 基质金属蛋白酶2及其抑制剂在大鼠青光眼滤过术后滤过泡组织中的动态表达.中华实验眼科杂志 2016; 34(4):324-329
    Related
    Cited by
Get Citation

Li Li. Protective effect of nerve growth factor combined with mecobalamine on optic nerve and influence on MMP-2 and TIMP-2. Guoji Yanke Zazhi( Int Eye Sci) 2018;18(12):2195-2198

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:July 13,2018
  • Revised:November 06,2018
  • Online: November 19,2018